Dyadic International Inc
DYAI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213809
In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Dyadic International Inc changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 33 | 33 | 0 |
| Shares | 4.50M | 4.52M | +12.9K (+0.3%) |
| Value | $7.25M | $7.54M | +$295.0K (+4.1%) |
New holders (5)
Institutions that held Dyadic International Inc at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HighTower Advisors, LLC | 77,319 | $129.0K | 0.00% |
| Callan Capital, LLC | 27,174 | $45.4K | 0.00% |
| Hoey Investments, Inc | 9,847 | $16.4K | 0.00% |
| Group One Trading, L.P. | 206 | $344 | 0.00% |
| FMR LLC | 150 | $251 | 0.00% |
Sold out (5)
Institutions that held Dyadic International Inc at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Equitable Holdings, Inc. | 19,250 | $31.0K |
| Bank of New York Mellon Corp | 12,574 | $20.2K |
| UBS Group AG | 4,517 | $7.27K |
| Simplex Trading, LLC | 1,271 | $2.00K |
| Bank of America Corp | 13 | $21 |